The Minimal Arsenic Concentration Required to Inhibit the Activity of Thyroid Peroxidase Activity In Vitro
- 8 August 2008
- journal article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 126 (1-3) , 49-55
Abstract
Arsenical compounds are known to interfere with normal thyroid function. Therefore, we designed an experiment to determine the minimal concentration of arsenic trioxide (As2O3) required to inhibit thyroid peroxidase (TPO) activity in vitro. The activity of commercially prepared human TPO was assayed spectrophotometrically in the absence (control) or presence of arsenic (0.1, 1.0, 5.0, and 10 ppm) during a 10-min incubation period. The results of this study indicate a significant dose–response relationship with the highest concentration of arsenic producing the greatest amount of TPO inhibition. Compared to controls, 0.1 ppm arsenic had no effect on TPO activity. Incubation for 2 min in the presence of 1.0, 5.0, or 10 ppm arsenic inhibited TPO activity to 4%, 9%, and 9% of control, respectively. After 10 min incubation in the presence of 1.0 or 5.0 ppm arsenic, TPO activity returned to 92% and 54% of control, respectively, while the presence of 10 ppm arsenic further inhibited TPO activity to 1% of control. In summary, arsenic trioxide inhibits in vitro TPO activity in a dose-dependent manner, and the minimal dose required to inhibit this activity is between 0.1 and 1 ppm.Keywords
This publication has 19 references indexed in Scilit:
- RETRACTED: Protection of Arsenic‐Induced Hepatic Disorder by Arjunolic AcidBasic & Clinical Pharmacology & Toxicology, 2007
- A Broad View of ArsenicPoultry Science, 2007
- Effect of long-term administration of arsenic (III) and bromine with and without selenium and iodine supplementation on the element level in the thyroid of ratBiomedical Papers, 2005
- Fish Arsenic May Influence Human Blood Arsenic, Selenium, and T4:T3 RatioBiological Trace Element Research, 2002
- Arsenic alters the function of the glucocorticoid receptor as a transcription factor.Environmental Health Perspectives, 2001
- Arsenic: health effects, mechanisms of actions, and research issues.Environmental Health Perspectives, 1999
- Evidence for arsenic essentialityEnvironmental Geochemistry and Health, 1992
- Thionamides and arsenite inhibit specific T3 binding to the hepatic nuclear receptorBiochemistry and Cell Biology, 1990
- Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs.Proceedings of the National Academy of Sciences, 1987
- INTERACTIONS BETWEEN ESSENTIAL TRACE AND ULTRATRACE ELEMENTSAnnals of the New York Academy of Sciences, 1980